Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval for Rezafungin for Candidemia and Invasive Candidiasis Treatment
Cidara Therapeutics and Melinta Therapeutics announced that the Antimicrobial Drugs Advisory Committee of the US Food and Drug Administration (FDA) authorised rezafungin to treat candidemia and invasi ...